Medication info
Vildaduo M Tablets 50/500 mg (Vildagliptin, Metformin Hydrochloride)

Vildaduo M Tablets 50/500 mg (Vildagliptin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Vildagliptin›50mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
Bright yellow oval film-coated tablets
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202302531 · Approved 2023.08.25 · Insurance code 622805130

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding 100mg of vildagliptin and 2000mg of metformin. Doses of vildagliptin greater than 100mg per day are not recommended. This medicine should generally be taken with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. For patients with no prior experience of antidiabetic drug treatment and inadequate glycemic control with monotherapy: The initial dose is 1 tablet of this medicine 50/500mg once daily. The dose may be gradually increased up to 1 tablet of 50/1000mg twice daily. Patients switching from combination therapy with vildagliptin and metformin: Patients switching from combination therapy with vildagliptin and metformin to this medicine may start at their existing doses of vildagliptin and metformin. If you forget to take this medicine, take it with your next meal unless it is time to take the missed dose. Do not take a double dose at one time to make up for a missed dose.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling their blood sugar when taken in combination with vildagliptin and metformin. It helps manage blood sugar effectively when combined with dietary control and exercise therapy. This stabilization helps in managing diabetes.

How to take

Adult dose

For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding 100mg of vildagliptin and 2000mg of metformin. Doses of vildagliptin greater than 100mg per day are not recommended. This medicine should generally be taken with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. For patients with no prior experience of antidiabetic drug treatment and inadequate glycemic control with monotherapy: The initial dose is 1 tablet of this medicine 50/500mg once daily. The dose may be gradually increased up to 1 tablet of 50/1000mg twice daily. Patients switching from combination therapy with vildagliptin and metformin: Patients switching from combination therapy with vildagliptin and metformin to this medicine may start at their existing doses of vildagliptin and metformin. If you forget to take this medicine, take it with your next meal unless it is time to take the missed dose. Do not take a double dose at one time to make up for a missed dose.

Precautions

This medication is used for the treatment of diabetes and contains two active ingredients. You must confirm that kidney function is normal before taking this medication, and patients with severely impaired kidney function should not take this medication. Additionally, patients whose kidney function is compromised due to severe heart failure, acute myocardial infarction, sepsis, etc., should avoid taking this medication. This medication can cause a serious side effect known as lactic acidosis, which is a condition characterized by increased blood lactate levels and acidosis. Though rare, it can be fatal, so caution is required. Particularly, if dehydration, severe diarrhea, vomiting, or fever occurs, this medication should be stopped immediately, and medical consultation should be sought. Patients with liver dysfunction should also avoid taking this medication, and regular liver function tests should be conducted during treatment. This medication can cause hypoglycemia, so extra caution is necessary in cases of irregular or insufficient food intake, vigorous exercise, or when taken with other blood sugar-lowering agents. Pregnant or nursing women should not take this medication, and its use is not recommended for children or teenagers under 18 years old. Elderly patients may have decreased kidney function, so it is important to check kidney function before use and monitor regularly. Patients scheduled for surgery should stop taking this medication 48 hours prior to surgery and should only resume after confirming that kidney function is normal post-surgery. Excessive alcohol consumption increases the risk of lactic acidosis; therefore, alcohol should be avoided during treatment with this medication. Moreover, this medication may interact with other drugs, so patients taking other medications should inform their physician or pharmacist. If abnormal symptoms occur during treatment, such as abdominal pain, shortness of breath, muscle pain, weakness, hypothermia, or changes in consciousness, immediate consultation with medical personnel is needed. This medication is not for patients with type 1 diabetes who require insulin treatment. Lastly, this medication should be stored out of reach of children, and changing the container is not safe.

Side effects

severe lactic acidosis, hypoglycemia, hepatitis, liver dysfunction, elevated transaminase levels, angioedema, tremors, headaches, dizziness, fatigue, nausea, hypoglycemia, gastroesophageal reflux, diarrhea, bloating, chills, decreased blood sugar, asthenia, hyperhidrosis, constipation, arthralgia, upper respiratory infection, rhinitis, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, taste disorder, erythema, itching, urticaria, pancreatitis, blisters, exfoliative skin lesions, severe and disability-associated arthralgia, cutaneous vasculitis, cholecystitis, dyspepsia, abdominal discomfort, gastrointestinal disturbances, elevated serum amylase, increased lipase levels, vesicular pemphigoid

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture and kept in a cool place below 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.